Organon (OGN) Deferred Taxes (2020 - 2026)

Organon (OGN) posted quarterly Deferred Taxes of $3.0 million for Q1 2026, up 117.65% year-over-year from $1.4 million in Q1 2025, and down 90.0% on a QoQ basis from $30.0 million in Q4 2025.

Organon (OGN) Deferred Taxes (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Deferred Taxes for 7 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Deferred Taxes rose 117.65% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $83.0 million (up 145.6% YoY), while the FY2025 annual figure was $63.0 million, up 139.37% from the prior year.
  • Deferred Taxes came in at $3.0 million for Q1 2026 at Organon, down from $30.0 million in the prior quarter.
  • The five-year high for Deferred Taxes was $40.0 million in Q3 2025, with the low at -$489.0 million in Q4 2023.
  • Average Deferred Taxes over 5 years is -$36.3 million, with a median of $3.0 million recorded in 2023.
  • The largest YoY upside for Deferred Taxes was 400.0% in 2024 against a maximum downside of 2550.0% in 2024.
  • Year by year, Deferred Taxes stood at -$20.0 million in 2022, then slumped by 2345.0% to -$489.0 million in 2023, then jumped by 102.04% to $10.0 million in 2024, then soared by 200.0% to $30.0 million in 2025, then tumbled by 90.0% to $3.0 million in 2026.
  • According to Business Quant data, Deferred Taxes over the past three periods registered $3.0 million, $30.0 million, and $40.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 1.48 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 159.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 137.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -315.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -176.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 179.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -12.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 3.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.00 Mn
Dec 31, 2025 30.00 Mn
Sep 30, 2025 40.00 Mn
Jun 30, 2025 10.00 Mn
Mar 31, 2025 -17.00 Mn
Dec 31, 2024 10.00 Mn
Sep 30, 2024 -196.00 Mn
Jun 30, 2024 21.00 Mn
Mar 31, 2024 5.00 Mn
Dec 31, 2023 -489.00 Mn
Sep 30, 2023 8.00 Mn
Jun 30, 2023 -7.00 Mn
Mar 31, 2023 3.00 Mn
Dec 31, 2022 -20.00 Mn
Sep 30, 2022 -9.00 Mn
Jun 30, 2022 -5.00 Mn
Mar 31, 2022 -4.00 Mn
Dec 31, 2021 -76.00 Mn
Sep 30, 2021 -41.00 Mn
Jun 30, 2021 -146.00 Mn